Fesseha T, Sakr W, Grignon D, Banerjee M, Wood D P, Pontes J E
Department of Urology, Wayne State University, Detroit, Michigan, USA.
J Urol. 1997 Dec;158(6):2176-9. doi: 10.1016/s0022-5347(01)68189-8.
We evaluated the prognostic implication of a positive surgical margin at the prostatic apex to define the risk of failure after radical prostatectomy.
Radical prostatectomy specimens of 590 patients operated on between 1990 and 1994 were reviewed by 2 uropathologists (D. G. and W. S.) to determine the percentage of patients with a positive margin at the apex in the absence of positive margins, extraprostatic extension or involvement of seminal vesicles and pelvic lymph nodes. In this group of 33 patients, the significance of a positive apex could be determined without the influence of any other stage related prognostic factors. Treatment failure was defined as prostate specific antigen greater than 0.4. All 33 patients have been followed between 3.5 and 65.5 months (median 38.7).
Among 590 patients 236 (40%) had disease completely confined to the prostate. A total of 217 patients (37%) had either positive surgical margins (M+) or extraprostatic extension and of these, only 33 (5.5%) had an apical positive margin in an otherwise prostate confined tumor. Of 33 apical positive margin patients only 3 in whom surgery failed had progressively detectable prostate specific antigen 3.5 to 65.5 months after surgery.
A positive surgical margin at the prostatic apex in the absence of positive margins or extraprostatic extension elsewhere does not confer a worse prognosis than organ confined disease. In this study the recurrence rate for patients with positive apical margins was the same as for those with confined disease.
我们评估了前列腺尖部手术切缘阳性的预后意义,以确定根治性前列腺切除术后的失败风险。
由2名泌尿病理学家(D.G.和W.S.)对1990年至1994年间接受手术的590例患者的根治性前列腺切除术标本进行复查,以确定在无切缘阳性、前列腺外侵犯或精囊及盆腔淋巴结受累的情况下,尖部切缘阳性患者的比例。在这33例患者中,可以在不受到任何其他与分期相关的预后因素影响的情况下确定尖部切缘阳性的意义。治疗失败定义为前列腺特异性抗原大于0.4。所有33例患者的随访时间为3.5至65.5个月(中位时间38.7个月)。
在590例患者中,236例(40%)疾病完全局限于前列腺。共有217例患者(37%)有手术切缘阳性(M+)或前列腺外侵犯,其中只有33例(5.5%)在其他方面前列腺局限的肿瘤中存在尖部切缘阳性。在33例尖部切缘阳性的患者中,只有3例手术失败,术后3.5至65.5个月前列腺特异性抗原逐渐可检测到。
在无其他部位切缘阳性或前列腺外侵犯的情况下,前列腺尖部手术切缘阳性并不比局限于器官的疾病预后更差。在本研究中,尖部切缘阳性患者的复发率与局限疾病患者相同。